←Pulmonary & Critical Care
COPD exacerbation
📚
🚬

COPD exacerbation

Bronchodilators, 5 days of prednisone, who gets antibiotics, BiPAP thresholds and discharge bundle.

COPDAECOPDBiPAPGOLD
🗓️ Reviewed 2026-11-18 · ⏱️ 3 min read · 📖 GOLD 2026 report · 2017 ERS/ATS NIV guideline · REDUCE trial
🧠 Pathophysiology in 60 seconds🔎 Diagnosis💊 Management🏠 Discharge bundle⚠️ Pitfalls🎓 Board corner📚 References
⚡ Bottom line — first hour
  • SpO₂ target 88–92%. Too much O₂ → more CO₂ retention.
  • Albuterol + ipratropium nebs, prednisone 40 mg × 5 days.
  • Antibiotics if more sputum purulence + more dyspnea or volume, or if on NIV/ventilator.
  • BiPAP if pH <7.35 and PaCO₂ >45 — it saves lives and avoids intubation.
  • Rule out the mimics: PE, HF, pneumonia, pneumothorax, ACS.
  • Discharge: long-acting inhalers, pulmonary rehab within 4 weeks, smoking cessation, vaccines.

🧠 Pathophysiology in 60 seconds

⌄
  • Trigger (virus ~50%, bacteria, pollution) → more airway inflammation, mucus and bronchospasm.
  • Air trapping (dynamic hyperinflation): the patient cannot breathe out fully before the next breath → flat diaphragm, high work of breathing → fatigue → CO₂ rises.
  • O₂ excess worsens hypercapnia by V/Q mismatch (loss of hypoxic vasoconstriction) and the Haldane effect — not mainly "loss of drive."

🔎 Diagnosis

⌄
  • Exacerbation (GOLD/Rome): dyspnea and/or cough-sputum worse within ≤14 days.
  • Severity (Rome): mild / moderate / severe by RR, HR, SpO₂, CRP, and ABG (PaCO₂, pH).
  • Workup: VBG/ABG, CXR, ECG, CBC (eosinophils), BMP, BNP/troponin if cardiac doubt, viral PCR; CTPA if PE suspected (PE is found in ~1 in 6 unexplained exacerbations).

💊 Management

⌄
1Hypercapnic acidosis (pH <7.35, PaCO₂ >45)?
Yes → BiPAP: IPAP 10–12 / EPAP 5; ABG in 1–2 h. Worsening, can't protect airway → intubate.
No ↓ O₂ to 88–92% (Venturi mask or nasal cannula).
▼
2Bronchodilators
Yes → Albuterol 2.5 mg + ipratropium 0.5 mg neb q4–6 h (albuterol q1–2 h as needed early).
▼
3Steroids
Yes → Prednisone 40 mg PO daily × 5 days (IV only if cannot take PO).
▼
4Antibiotics?
Yes → Purulent sputum + 1 other cardinal symptom, or on NIV/MV → 5 days.
Antibiotic choice When
Azithromycin 500 mg day 1 → 250 mg × 4 d Uncomplicated
Doxycycline 100 mg BID Uncomplicated
Amoxicillin-clavulanate 875 mg BID Older, frequent exacerbations, FEV₁ <50%
Levofloxacin 750 mg / cefepime / pip-tazo Pseudomonas risk (bronchiectasis, prior isolate, frequent abx)
💡 Pearl

Eosinophils ≥300 predict steroid and ICS response. Low eosinophils → lower steroid benefit.

🏠 Discharge bundle

⌄
  • ☐ Inhaler technique checked; LAMA + LABA; add ICS if eosinophils ≥300, or ≥100 with frequent exacerbations (avoid ICS with recurrent pneumonia)
  • ☐ Biologic referral (dupilumab/mepolizumab) if eos ≥300 and exacerbations despite triple therapy
  • ☐ Pulmonary rehab within 4 weeks
  • ☐ Smoking cessation (varenicline/NRT); vaccines (influenza, COVID, pneumococcal, RSV ≥60, Tdap)
  • ☐ Home O₂ evaluation (resting SpO₂ ≤88% or PaO₂ ≤55)
  • ☐ Follow-up within 1–4 weeks; action plan

⚠️ Pitfalls

⌄
  • 100% non-rebreather in a CO₂ retainer.
  • Missing PE or HF as the real cause.
  • 14-day steroid tapers (no benefit over 5 days).
  • BiPAP delaying needed intubation.

🎓 Board corner

⌄
Stem Answer
pH 7.28, PaCO₂ 68, alert BiPAP
pH 7.15, drowsy, vomiting Intubate
Exacerbation, purulent sputum, more dyspnea Antibiotics + steroids
Best long-term survival interventions Smoking cessation, O₂ (if hypoxemic), (LVR/transplant selected)
Steroid duration 5 days (REDUCE)

📚 References

⌄
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2026 Report.
  • Rochwerg B, et al. ERS/ATS NIV guideline. Eur Respir J. 2017;50:1602426.
  • Leuppi JD, et al. REDUCE. JAMA. 2013;309:2223.
  • Celli BR, et al. Rome proposal for exacerbations. AJRCCM. 2021.
↩︎ Back to 🫁 Pulmonary & Critical Care